Skip to main content

Table 2 Research hypotheses and verification

From: Determinants of the willingness to participate in biobanking among Malaysian stakeholders in the Klang Valley

Research hypothesis

Conclusion

H1 (Engagement âž” Perceived benefits)

When stakeholders are more engaged with modern biotechnology, then they will perceive higher benefits associated with biobanks.

Supported

H2 (Engagement âž” Issues of data & specimen protection)

When stakeholders are more engaged with biotechnology, then they will exhibit less concern regarding issues of data and specimen protection in biobanks.

Not Supported

H3 (Engagement âž” Religious acceptance)

When stakeholders are more engaged with biotechnology, then they will be more accepting of biobanks from a religious perspective.

Supported

H4 (Engagement âž” Willingness to participate)

When stakeholders are more engaged with biotechnology, then they will be more willing to participate in biobanking.

Not Supported

H5 (Trust in key players âž” Perceived benefits)

When stakeholders have more trust in key players involved in using or regulating modern biotechnology, then they will perceive stronger benefits associated with biobanks.

Supported

H6 (Trust in key players âž” Issues of data & specimen protection)

When stakeholders have more trust in key players involved in using or regulating modern biotechnology, then they will exhibit lower concerns regarding issues of data and specimen protection in biobanks.

Not Supported

H7 (Trust in key players âž” Religious acceptance)

When stakeholders have more trust in key players involved in using or regulating modern biotechnology, then they will be more accepting of biobanks from a religious perspective.

Not Supported

H8 (Trust in key players âž” Willingness to participate)

When stakeholders have more trust in key players involved in using or regulating modern biotechnology, then they will be more willing to participate in biobanking.

Supported

H9 (Attitude towards technology âž” Issues of data & specimen protection)

When stakeholders exhibit a strong negative predisposition towards science and technology, then they will exhibit stronger concerns regarding issues of data and specimen protection in biobanks.

Supported

H10 (Attitude towards technology âž” Religious acceptance)

When stakeholders exhibit a strong negative predisposition towards science and technology, then they will be less accepting of biobanks from a religious perspective.

Not Supported

H11 (Religiosity âž” Perceived benefits)

When stakeholders view themselves are more religious, then they will perceive stronger benefits associated with biobanks.

Supported

H12 (Religiosity âž” Issues of data & specimen protection)

When stakeholders view themselves as more religious, then they will exhibit stronger concerns regarding issues of data and specimen protection in biobanks.

Supported

H13 (Religiosity âž” Willingness to participate)

When stakeholders view themselves as more religious, then they will be more willing to participate in biobanking.

Not Supported

H14 (Issues of data & specimen protection âž” Perceived benefits)

When stakeholders have strong concerns regarding issues of data and specimen protection associated with biobanks, then they will perceive fewer benefits associated with biobanks.

Not Supported

H15 (Issues of data & specimen protection âž” Religious acceptance)

When stakeholders have stronger concerns regarding issues of data and specimen protection associated with biobanks, then they will be less accepting of biobanks from a religious perspective.

Supported

H16 (Issues of data & specimen protection âž” Willingness to participate)

When stakeholders have strong concerns about issues of data and specimen protection associated with biobanks, then they will be less willing to participate in biobanking.

Supported

H17 (Perceived benefits âž” Religious acceptance)

When stakeholders perceive stronger benefits associated with biobanks, then they will be more accepting of biobanks from a religious perspective.

Supported

H18 (Perceived benefits âž” Willingness to participate)

When stakeholders perceive stronger benefits associated with biobanks, then they be more willing to participate in biobanking.

Supported

H19 (Religious acceptance âž” Willingness to participate)

When stakeholders are more accepting of biobanks from a religious perspective, then they will be more willing to participate in biobanking.

Supported